Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference56 articles.
1. A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test;Choi;Cancer Chemother Pharmacol,2015
2. Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902;Sugawara;Ann Oncol,2015
3. Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: a case report;Watanabe;Exp Ther Med,2015
4. Relationship among gefitinib exposure, polymorphisms of its metabolizing enzymes and transporters, and side effects in Japanese patients with non-small-cell lung cancer;Kobayashi;Clin Lung Cancer,2015
5. A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors;Lam;Mol Cancer Ther,2008
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lung Cancer and Interstitial Lung Diseases;Cancers;2024-08-13
2. Repeat biopsy versus initial biopsy in terms of complication risk factors and clinical outcomes for patients with non-small cell lung cancer: a comparative study of 113 CT-guided needle biopsy of lung lesions;Frontiers in Oncology;2024-05-13
3. Valsartan prevents gefitinib-induced lung inflammation, oxidative stress, and alteration of plasma metabolites in rats;Saudi Journal of Biological Sciences;2023-02
4. CYSTIC LUNG DISEASE IN A PATIENT WITH METASTATIC LUNG ADENOCARCINOMA TREATED WITH LONG-TERM ERLOTINIB;Chest;2022-10
5. Pulmonary toxicity in driver gene positive non-small cell lung cancer therapy;Current Medical Research and Opinion;2022-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3